The Arterial Revascularization Therapies Study Part II.
NCT00235170
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
607
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
drug-eluting stent
Sponsor
Cordis US Corp.